9 METERS BIOPHARMA, INC. Quarterly Liabilities, Current in USD from Q4 2015 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary
9 Meters Biopharma, Inc. quarterly Liabilities, Current history and growth rate from Q4 2015 to Q1 2023.
  • 9 Meters Biopharma, Inc. Liabilities, Current for the quarter ending March 31, 2023 was $15.6M, a 89.4% increase year-over-year.
Liabilities, Current, Quarterly (USD)
Liabilities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 $15.6M +$7.35M +89.4% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $30.7M +$22.2M +263% Dec 31, 2022 10-Q 2023-05-15
Q3 2022 $12.9M +$5.58M +76.7% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $9.34M +$2.62M +39.1% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $8.22M +$2.24M +37.4% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $8.46M +$1.61M +23.5% Dec 31, 2021 10-K 2023-03-28
Q3 2021 $7.28M -$2.83M -28% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $6.72M -$4.9M -42.2% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $5.99M -$9.85M -62.2% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $6.85M -$8.06M -54.1% Dec 31, 2020 10-K 2022-03-23
Q3 2020 $10.1M -$3.02M -23% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $11.6M +$2M +20.8% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 $15.8M +$4.89M +44.7% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 $14.9M +$4.8M +47.4% Dec 31, 2019 10-K 2021-03-22
Q3 2019 $13.1M +$4.82M +58.1% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $9.62M +$2.12M +28.3% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $10.9M +$5.51M +101% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 $10.1M -$2.86M -22% Dec 31, 2018 10-K 2020-03-20
Q3 2018 $8.3M +$3.43M +70.2% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 $7.5M +$3.74M +99.3% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 $5.44M +$2M +58.2% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 $13M +$9M +226% Dec 31, 2017 10-K 2019-03-18
Q3 2017 $4.88M -$664K -12% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 $3.76M -$8.4M -69.1% Jun 30, 2017 10-Q 2017-08-21
Q1 2017 $3.44M Mar 31, 2017 10-Q 2017-05-19
Q4 2016 $3.98M -$6.44M -61.8% Dec 31, 2016 10-K 2018-03-14
Q3 2016 $5.54M Sep 30, 2016 10-Q 2016-11-16
Q2 2016 $12.2M Jun 30, 2016 10-Q 2016-08-15
Q4 2015 $10.4M Dec 31, 2015 10-K 2017-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.